Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/52-more-drugs-brought-under-price-ceiling-4674789/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/52-more-drugs-brought-under-price-ceiling-4674789/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/52-more-drugs-brought-under-price-ceiling-4674789/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/52-more-drugs-brought-under-price-ceiling-4674789/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f1f0b3a6cb6-trace').style.display = (document.getElementById('cakeErr67f1f0b3a6cb6-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f1f0b3a6cb6-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f1f0b3a6cb6-code').style.display = (document.getElementById('cakeErr67f1f0b3a6cb6-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f1f0b3a6cb6-context').style.display = (document.getElementById('cakeErr67f1f0b3a6cb6-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f1f0b3a6cb6-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f1f0b3a6cb6-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26747,
		&#039;title&#039; =&gt; &#039;52 more drugs brought under price ceiling&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-Business Standard
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;This would be in addition to 348 drugs already under price ceiling&lt;/em&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &amp;quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.&lt;br /&gt;
 
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA&#039;s move in July.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;strong&gt;ON A TIGHT LEASH&lt;/strong&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;strong&gt;    &lt;/strong&gt;Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics&lt;br /&gt;
    Lupin, Cadila Healthcare, Merck, could be affected following the order&lt;br /&gt;
    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs&lt;br /&gt;
    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM&lt;br /&gt;
    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Business Standard, 13 December, 2014, http://www.business-standard.com/article/economy-policy/52-more-drugs-to-come-under-price-ceiling-could-impact-pharma-cos-114121200989_1.html&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;52-more-drugs-brought-under-price-ceiling-4674789&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674789,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26747,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | 52 more drugs brought under price ceiling&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines,medicine,medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-Business Standard


This would be in addition to 348 drugs already under price ceiling


The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.


This...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-Business Standard&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;This would be in addition to 348 drugs already under price ceiling&lt;/em&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &amp;quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.&lt;br /&gt; &lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA&#039;s move in July.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;ON A TIGHT LEASH&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;    &lt;/strong&gt;Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics&lt;br /&gt;    Lupin, Cadila Healthcare, Merck, could be affected following the order&lt;br /&gt;    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs&lt;br /&gt;    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM&lt;br /&gt;    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26747,
	&#039;title&#039; =&gt; &#039;52 more drugs brought under price ceiling&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-Business Standard
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;This would be in addition to 348 drugs already under price ceiling&lt;/em&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &amp;quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.&lt;br /&gt;
 
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA&#039;s move in July.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;strong&gt;ON A TIGHT LEASH&lt;/strong&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;strong&gt;    &lt;/strong&gt;Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics&lt;br /&gt;
    Lupin, Cadila Healthcare, Merck, could be affected following the order&lt;br /&gt;
    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs&lt;br /&gt;
    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM&lt;br /&gt;
    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Business Standard, 13 December, 2014, http://www.business-standard.com/article/economy-policy/52-more-drugs-to-come-under-price-ceiling-could-impact-pharma-cos-114121200989_1.html&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;52-more-drugs-brought-under-price-ceiling-4674789&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674789,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26747
$metaTitle = &#039;LATEST NEWS UPDATES | 52 more drugs brought under price ceiling&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines,medicine,medicines&#039;
$metaDesc = &#039;
-Business Standard


This would be in addition to 348 drugs already under price ceiling


The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.


This...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-Business Standard&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;This would be in addition to 348 drugs already under price ceiling&lt;/em&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &amp;quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.&lt;br /&gt; &lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA&#039;s move in July.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;ON A TIGHT LEASH&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;    &lt;/strong&gt;Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics&lt;br /&gt;    Lupin, Cadila Healthcare, Merck, could be affected following the order&lt;br /&gt;    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs&lt;br /&gt;    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM&lt;br /&gt;    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/52-more-drugs-brought-under-price-ceiling-4674789.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | 52 more drugs brought under price ceiling | Im4change.org</title>
    <meta name="description" content="
-Business Standard


This would be in addition to 348 drugs already under price ceiling


The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.


This..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>52 more drugs brought under price ceiling</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-Business Standard</div><p align="justify"><em>This would be in addition to 348 drugs already under price ceiling</em></p><p align="justify">The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.</p><p align="justify">This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.</p><p align="justify">The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.</p><p align="justify">Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&quot;</p><p align="justify">Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.<br /> </p><p align="justify">The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.</p><p align="justify">NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.</p><p align="justify">The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA's move in July.</p><p align="justify">In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.</p><p align="justify"><strong>ON A TIGHT LEASH</strong></p><p align="justify"><strong>    </strong>Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics<br />    Lupin, Cadila Healthcare, Merck, could be affected following the order<br />    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs<br />    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM<br />    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%</p><p align="justify">&nbsp;</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f1f0b3a6cb6-trace').style.display = (document.getElementById('cakeErr67f1f0b3a6cb6-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f1f0b3a6cb6-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f1f0b3a6cb6-code').style.display = (document.getElementById('cakeErr67f1f0b3a6cb6-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f1f0b3a6cb6-context').style.display = (document.getElementById('cakeErr67f1f0b3a6cb6-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f1f0b3a6cb6-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f1f0b3a6cb6-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26747,
		&#039;title&#039; =&gt; &#039;52 more drugs brought under price ceiling&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-Business Standard
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;This would be in addition to 348 drugs already under price ceiling&lt;/em&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &amp;quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.&lt;br /&gt;
 
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA&#039;s move in July.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;strong&gt;ON A TIGHT LEASH&lt;/strong&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;strong&gt;    &lt;/strong&gt;Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics&lt;br /&gt;
    Lupin, Cadila Healthcare, Merck, could be affected following the order&lt;br /&gt;
    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs&lt;br /&gt;
    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM&lt;br /&gt;
    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Business Standard, 13 December, 2014, http://www.business-standard.com/article/economy-policy/52-more-drugs-to-come-under-price-ceiling-could-impact-pharma-cos-114121200989_1.html&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;52-more-drugs-brought-under-price-ceiling-4674789&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674789,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26747,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | 52 more drugs brought under price ceiling&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines,medicine,medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-Business Standard


This would be in addition to 348 drugs already under price ceiling


The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.


This...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-Business Standard&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;This would be in addition to 348 drugs already under price ceiling&lt;/em&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &amp;quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.&lt;br /&gt; &lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA&#039;s move in July.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;ON A TIGHT LEASH&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;    &lt;/strong&gt;Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics&lt;br /&gt;    Lupin, Cadila Healthcare, Merck, could be affected following the order&lt;br /&gt;    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs&lt;br /&gt;    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM&lt;br /&gt;    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26747,
	&#039;title&#039; =&gt; &#039;52 more drugs brought under price ceiling&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-Business Standard
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;This would be in addition to 348 drugs already under price ceiling&lt;/em&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &amp;quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.&lt;br /&gt;
 
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA&#039;s move in July.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;strong&gt;ON A TIGHT LEASH&lt;/strong&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;strong&gt;    &lt;/strong&gt;Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics&lt;br /&gt;
    Lupin, Cadila Healthcare, Merck, could be affected following the order&lt;br /&gt;
    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs&lt;br /&gt;
    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM&lt;br /&gt;
    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Business Standard, 13 December, 2014, http://www.business-standard.com/article/economy-policy/52-more-drugs-to-come-under-price-ceiling-could-impact-pharma-cos-114121200989_1.html&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;52-more-drugs-brought-under-price-ceiling-4674789&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674789,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26747
$metaTitle = &#039;LATEST NEWS UPDATES | 52 more drugs brought under price ceiling&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines,medicine,medicines&#039;
$metaDesc = &#039;
-Business Standard


This would be in addition to 348 drugs already under price ceiling


The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.


This...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-Business Standard&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;This would be in addition to 348 drugs already under price ceiling&lt;/em&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &amp;quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.&lt;br /&gt; &lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA&#039;s move in July.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;ON A TIGHT LEASH&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;    &lt;/strong&gt;Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics&lt;br /&gt;    Lupin, Cadila Healthcare, Merck, could be affected following the order&lt;br /&gt;    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs&lt;br /&gt;    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM&lt;br /&gt;    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/52-more-drugs-brought-under-price-ceiling-4674789.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | 52 more drugs brought under price ceiling | Im4change.org</title>
    <meta name="description" content="
-Business Standard


This would be in addition to 348 drugs already under price ceiling


The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.


This..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>52 more drugs brought under price ceiling</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-Business Standard</div><p align="justify"><em>This would be in addition to 348 drugs already under price ceiling</em></p><p align="justify">The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.</p><p align="justify">This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.</p><p align="justify">The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.</p><p align="justify">Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&quot;</p><p align="justify">Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.<br /> </p><p align="justify">The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.</p><p align="justify">NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.</p><p align="justify">The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA's move in July.</p><p align="justify">In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.</p><p align="justify"><strong>ON A TIGHT LEASH</strong></p><p align="justify"><strong>    </strong>Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics<br />    Lupin, Cadila Healthcare, Merck, could be affected following the order<br />    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs<br />    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM<br />    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%</p><p align="justify">&nbsp;</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f1f0b3a6cb6-trace').style.display = (document.getElementById('cakeErr67f1f0b3a6cb6-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f1f0b3a6cb6-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f1f0b3a6cb6-code').style.display = (document.getElementById('cakeErr67f1f0b3a6cb6-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f1f0b3a6cb6-context').style.display = (document.getElementById('cakeErr67f1f0b3a6cb6-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f1f0b3a6cb6-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f1f0b3a6cb6-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 26747,
		&#039;title&#039; =&gt; &#039;52 more drugs brought under price ceiling&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-Business Standard
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;This would be in addition to 348 drugs already under price ceiling&lt;/em&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &amp;quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.&lt;br /&gt;
 
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA&#039;s move in July.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;strong&gt;ON A TIGHT LEASH&lt;/strong&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;strong&gt;    &lt;/strong&gt;Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics&lt;br /&gt;
    Lupin, Cadila Healthcare, Merck, could be affected following the order&lt;br /&gt;
    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs&lt;br /&gt;
    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM&lt;br /&gt;
    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;Business Standard, 13 December, 2014, http://www.business-standard.com/article/economy-policy/52-more-drugs-to-come-under-price-ceiling-could-impact-pharma-cos-114121200989_1.html&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;52-more-drugs-brought-under-price-ceiling-4674789&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4674789,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 26747,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | 52 more drugs brought under price ceiling&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines,medicine,medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-Business Standard


This would be in addition to 348 drugs already under price ceiling


The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.


This...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-Business Standard&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;This would be in addition to 348 drugs already under price ceiling&lt;/em&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &amp;quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.&lt;br /&gt; &lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA&#039;s move in July.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;ON A TIGHT LEASH&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;    &lt;/strong&gt;Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics&lt;br /&gt;    Lupin, Cadila Healthcare, Merck, could be affected following the order&lt;br /&gt;    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs&lt;br /&gt;    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM&lt;br /&gt;    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 26747,
	&#039;title&#039; =&gt; &#039;52 more drugs brought under price ceiling&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-Business Standard
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;em&gt;This would be in addition to 348 drugs already under price ceiling&lt;/em&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &amp;quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.&lt;br /&gt;
 
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA&#039;s move in July.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;strong&gt;ON A TIGHT LEASH&lt;/strong&gt;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;strong&gt;    &lt;/strong&gt;Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics&lt;br /&gt;
    Lupin, Cadila Healthcare, Merck, could be affected following the order&lt;br /&gt;
    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs&lt;br /&gt;
    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM&lt;br /&gt;
    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;Business Standard, 13 December, 2014, http://www.business-standard.com/article/economy-policy/52-more-drugs-to-come-under-price-ceiling-could-impact-pharma-cos-114121200989_1.html&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;52-more-drugs-brought-under-price-ceiling-4674789&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4674789,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 26747
$metaTitle = &#039;LATEST NEWS UPDATES | 52 more drugs brought under price ceiling&#039;
$metaKeywords = &#039;National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines,medicine,medicines&#039;
$metaDesc = &#039;
-Business Standard


This would be in addition to 348 drugs already under price ceiling


The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.


This...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-Business Standard&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;em&gt;This would be in addition to 348 drugs already under price ceiling&lt;/em&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &amp;quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.&lt;br /&gt; &lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA&#039;s move in July.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;ON A TIGHT LEASH&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&lt;strong&gt;    &lt;/strong&gt;Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics&lt;br /&gt;    Lupin, Cadila Healthcare, Merck, could be affected following the order&lt;br /&gt;    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs&lt;br /&gt;    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM&lt;br /&gt;    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/52-more-drugs-brought-under-price-ceiling-4674789.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | 52 more drugs brought under price ceiling | Im4change.org</title>
    <meta name="description" content="
-Business Standard


This would be in addition to 348 drugs already under price ceiling


The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.


This..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>52 more drugs brought under price ceiling</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-Business Standard</div><p align="justify"><em>This would be in addition to 348 drugs already under price ceiling</em></p><p align="justify">The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.</p><p align="justify">This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.</p><p align="justify">The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.</p><p align="justify">Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&quot;</p><p align="justify">Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.<br /> </p><p align="justify">The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.</p><p align="justify">NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.</p><p align="justify">The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA's move in July.</p><p align="justify">In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.</p><p align="justify"><strong>ON A TIGHT LEASH</strong></p><p align="justify"><strong>    </strong>Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics<br />    Lupin, Cadila Healthcare, Merck, could be affected following the order<br />    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs<br />    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM<br />    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%</p><p align="justify">&nbsp;</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 26747,
		'title' => '52 more drugs brought under price ceiling',
		'subheading' => '',
		'description' => '<div align="justify">
-Business Standard
</div>
<p align="justify">
<em>This would be in addition to 348 drugs already under price ceiling</em>
</p>
<p align="justify">
The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.
</p>
<p align="justify">
This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.
</p>
<p align="justify">
The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.
</p>
<p align="justify">
Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&quot;
</p>
<p align="justify">
Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.<br />
 
</p>
<p align="justify">
The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.
</p>
<p align="justify">
NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.
</p>
<p align="justify">
The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA's move in July.
</p>
<p align="justify">
In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.
</p>
<p align="justify">
<strong>ON A TIGHT LEASH</strong>
</p>
<p align="justify">
<strong>    </strong>Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics<br />
    Lupin, Cadila Healthcare, Merck, could be affected following the order<br />
    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs<br />
    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM<br />
    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%
</p>
<p align="justify">
&nbsp;
</p>',
		'credit_writer' => 'Business Standard, 13 December, 2014, http://www.business-standard.com/article/economy-policy/52-more-drugs-to-come-under-price-ceiling-could-impact-pharma-cos-114121200989_1.html',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => '52-more-drugs-brought-under-price-ceiling-4674789',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4674789,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 26747,
	'metaTitle' => 'LATEST NEWS UPDATES | 52 more drugs brought under price ceiling',
	'metaKeywords' => 'National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines,medicine,medicines',
	'metaDesc' => '
-Business Standard


This would be in addition to 348 drugs already under price ceiling


The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.


This...',
	'disp' => '<div align="justify">-Business Standard</div><p align="justify"><em>This would be in addition to 348 drugs already under price ceiling</em></p><p align="justify">The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.</p><p align="justify">This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.</p><p align="justify">The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.</p><p align="justify">Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&quot;</p><p align="justify">Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.<br /> </p><p align="justify">The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.</p><p align="justify">NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.</p><p align="justify">The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA's move in July.</p><p align="justify">In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.</p><p align="justify"><strong>ON A TIGHT LEASH</strong></p><p align="justify"><strong>    </strong>Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics<br />    Lupin, Cadila Healthcare, Merck, could be affected following the order<br />    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs<br />    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM<br />    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%</p><p align="justify">&nbsp;</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 26747,
	'title' => '52 more drugs brought under price ceiling',
	'subheading' => '',
	'description' => '<div align="justify">
-Business Standard
</div>
<p align="justify">
<em>This would be in addition to 348 drugs already under price ceiling</em>
</p>
<p align="justify">
The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.
</p>
<p align="justify">
This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.
</p>
<p align="justify">
The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.
</p>
<p align="justify">
Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&quot;
</p>
<p align="justify">
Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.<br />
 
</p>
<p align="justify">
The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.
</p>
<p align="justify">
NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.
</p>
<p align="justify">
The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA's move in July.
</p>
<p align="justify">
In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.
</p>
<p align="justify">
<strong>ON A TIGHT LEASH</strong>
</p>
<p align="justify">
<strong>    </strong>Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics<br />
    Lupin, Cadila Healthcare, Merck, could be affected following the order<br />
    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs<br />
    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM<br />
    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%
</p>
<p align="justify">
&nbsp;
</p>',
	'credit_writer' => 'Business Standard, 13 December, 2014, http://www.business-standard.com/article/economy-policy/52-more-drugs-to-come-under-price-ceiling-could-impact-pharma-cos-114121200989_1.html',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => '52-more-drugs-brought-under-price-ceiling-4674789',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4674789,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {},
		(int) 5 => object(Cake\ORM\Entity) {},
		(int) 6 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 26747
$metaTitle = 'LATEST NEWS UPDATES | 52 more drugs brought under price ceiling'
$metaKeywords = 'National Pharmaceutical Pricing Authority (NPPA),nppa,Access to Health,Access to Healthcare,Access to Medicines,medicine,medicines'
$metaDesc = '
-Business Standard


This would be in addition to 348 drugs already under price ceiling


The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.


This...'
$disp = '<div align="justify">-Business Standard</div><p align="justify"><em>This would be in addition to 348 drugs already under price ceiling</em></p><p align="justify">The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck.</p><p align="justify">This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders.</p><p align="justify">The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share.</p><p align="justify">Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, &quot;Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing.&quot;</p><p align="justify">Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at   Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451.<br /> </p><p align="justify">The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable.</p><p align="justify">NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013.</p><p align="justify">The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA's move in July.</p><p align="justify">In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs.</p><p align="justify"><strong>ON A TIGHT LEASH</strong></p><p align="justify"><strong>    </strong>Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics<br />    Lupin, Cadila Healthcare, Merck, could be affected following the order<br />    NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs<br />    At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM<br />    Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%</p><p align="justify">&nbsp;</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

52 more drugs brought under price ceiling

-Business Standard This would be in addition to 348 drugs already under price ceiling The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck. This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin disorders. The government caps prices of regulated medicines based on a simple average of prices of all drugs in the segment with over one per cent market share. Reacting to the latest order by NPPA on Friday, a spokesperson of Lupin said, "Though Lupin will not see any impact, we have always maintained that competition is a great leveler and the market finds its own level when it comes to matters such as pricing." Following the NPPA order, shares of Cadila Healthcare settled more than two per cent lower on the BSE exchange at Rs 1,582.35 on Friday. Shares of Lupin, however, ended one per cent higher at Rs 1,451. The NPPA order asks manufacturers of these scheduled formulations to reduce the maximum retail price of the drugs wherever the existing rate exceeds the ceiling. For prices already below the ceiling, manufacturers can maintain the existing maximum retail price. The manufacturer may add local taxes only if these have been actually paid or are payable. NPPA said where a manufacturer of these formulations with dosage or strength or both as specified launch a new drug, it shall apply for prior approval under the Drug Price Control Order, 2013. The move comes after NPPA was forced to withdraw pricing powers of 108 non-essential medicines following a government directive. Drug companies operating in India had cheered the move then, but the latest order may set things one up with the regulator exercising its pricing power. In fact, companies had challenged in court the NPPA order bringing down prices of 108 non-essential drugs by invoking the public interest. Industry bodies such as the Indian Pharmaceutical Association and the Organisation of Pharmaceutical Producers of India went to court against the NPPA's move in July. In its notification, NPPA set prices of formulations based on bulk drugs for paracetamol, bleaching powder, ketamine hydrochloride, zinc sulfate, ascorbic acid, cloxacillin, gentamycin, glucose, glucose with normal saline, mannitol, amoxycilline with potassium clavulanate, metoprolol succinate with cilnidipine (cardiocil M), and a number of other combination drugs. ON A TIGHT LEASH Used for cancer and skin disorders, the capped drugs are primarily painkillers and antibiotics Lupin, Cadila Healthcare, Merck, could be affected following the order NPPA had to withdraw a May order that gave the regulator capping prices of 108 non essential drugs At present, NPPA regulates prices of 348 medicine formulations listed in the NLEM Govt caps pricing of regulated medicines based on a simple average of prices of all drugs in the segment with over 1%